Strain-Insensitive, Crosstalk-Suppressed, Ultrawide-Linearity Iontronic Tactile Skin from a Synergistic Segment-Embedded Strategy by Yanchao Zhao (5129174)

Heavy metal EF values in five soil profiles. by Ziqi Li (7154915)

“…Except for profile HCZK02, the contents of 8 heavy metals generally decrease with increasing depth. As the depth of profile HCZK02 increases, As, Hg and Pb show a decrease-increase-decrease change; Cd and Cr show a decrease change and Ni shows a zigzag change; Cu and Zn show a decreasing-increasing-decreasing-increasing trend. …”

Glycochenodexycholic (GCDCA) causes lumen obstruction and subepithelial fibrosis of neonatal extrahepatic bile ducts (EHBDs), while ursodeoxycholic acid (UDCA) attenuates GCDCA tox... by Miri Dotan (12250909)

“…<p>(a) Neonatal EHBD were dissected and incubated for 24 hours in biliary epithelial cell media, with or without GCDCA 5mM, and with GCDCA 5mM combined with UDCA acid 5mM. …”

Data_Sheet_2_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

“…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”

Data_Sheet_1_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

“…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”

Data_Sheet_3_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

“…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”

Data_Sheet_4_Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network... by Fen Cao (4496014)

“…To compare the effectiveness and safety of endothelin receptor antagonists (ERAs), phosphodiesterase type 5 Inhibitors (PDE-5i), and prostaglandins (ProA) in the treatment of pediatric PAH, we investigated six hemodynamic parameters, four respiratory parameters, intensive care unit (ICU) stay duration, length of hospital stay, and two safety outcomes.…”

Changes in expression of ATF-3 and NeuN in the DRGs of PSNL-exposed rats and the effects of treatment with MSCs. by Kanako Miyano (3805288)

Cardiac valve malformation impacts crawling and movement of larvae. by Christian Meyer (6035)

Table_1_Rapid outpatient transient ischemic attack clinic and stroke service activity during the SARS-CoV-2 pandemic: a multicenter time series analysis.docx by Andy Lim (5825183)

“…</p>Results<p>Six centers provided data for a total of 6,231 TIA and 13,191 ischemic stroke presentations from Australia (52.1%), Canada (35.0%), Italy (7.6%), and England (5.4%). …”

Changes in expression of myelin basic protein (MBP) and neurofilament heavy polypeptide (NF200) in the sciatic nerves of PSNL-exposed rats and the effects of treatment with MSCs. by Kanako Miyano (3805288)

miR-200c regulates migration associated genes such as filamin A. by Bojan Ljepoja (4921255)

“…(RT qPCR showed that after adding 5 μg / ml doxycycline for 48 h the expression of FLNA mRNA (b) as well as filamin A protein(c) (normalized to tubulin) decreased significantly in MDA-MB 231 TRIPZ 200c cells. …”

CRNN over-expression promotes the growth of cSCC xenografts in vivo. by Changji Li (4806930)

Pharmacokinetics and pharmacodynamics of compound 4f in mice. by Naoto Arimura (416442)

Map of eastern Uganda with an extract showing study sites. by Moses R. Kamya (8308617)

Targeting Forkhead box O1-aquaporin 5 axis mitigates neuropathic pain in a CCI rat model through inhibiting astrocytic and microglial activation by Yaoping Yu (12289572)

“…Inhibition of FoxO1 or AQP5 dramatically decreased the LPS-induced inflammation in microglia and astrocytes. …”

Image3_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

“…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”

Image1_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpg by Heather A. Ogana (11774297)

“…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”

Image2_Artemis inhibition as a therapeutic strategy for acute lymphoblastic leukemia.jpeg by Heather A. Ogana (11774297)

“…We compared these 4 compounds to a DNA-PK inhibitor (AZD7648) in three patient-derived B-ALL cell lines (LAX56, BLQ5 and LAX7R) and in two mature B-cell lines (3301015 and 5680001) as controls. …”

Supporting information file corresponding to Fig 7. by Oswaldo Maillard (20660661)